Clinical Trials on Angiomatoid Fibrous Histiocytoma
Total 5609 results
-
Ark Biosciences Inc.Shanghai Ark Biopharmaceutical Co., Ltd.Not yet recruitingA Study to Evaluate the Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary FibrosisIdiopathic Pulmonary FibrosisChina
-
The Affiliated Hospital of Qingdao UniversityRecruitingLiver Fibrosis After Liver Transplantation | Multiparameter Magnetic Resonance ImagingChina
-
The Foundation for Orthopaedics and Regenerative...RecruitingIdiopathic Pulmonary FibrosisAntigua and Barbuda, Argentina, Mexico
-
HuniLife Biotechnology, Inc.RecruitingIdiopathic Pulmonary FibrosisTaiwan
-
Seoul National University HospitalRecruiting
-
Assistance Publique - Hôpitaux de ParisRecruitingIdiopathic Pulmonary FibrosisFrance
-
Dai HuapingRecruiting
-
Royal Brompton & Harefield NHS Foundation TrustCompletedIdiopathic Pulmonary FibrosisUnited Kingdom
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisIndia
-
Galapagos NVTerminatedIdiopathic Pulmonary FibrosisUnited States, Spain, Japan, Belgium, Taiwan, Denmark, Germany, United Kingdom, Greece, Australia, Czechia, Brazil, Chile, Peru, Turkey
-
Galapagos NVTerminatedIdiopathic Pulmonary FibrosisUnited States, Netherlands, Korea, Republic of, Israel, Japan, New Zealand, France, Italy, Argentina, Germany, Hungary, South Africa, Poland, Canada, Mexico
-
patientMpower Ltd.Boehringer IngelheimTerminatedIdiopathic Pulmonary FibrosisIreland
-
Royal Brompton & Harefield NHS Foundation TrustActive, not recruiting
-
Vanderbilt University Medical CenterGenentech, Inc.CompletedIdiopathic Pulmonary FibrosisUnited States
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisUnited States, Netherlands
-
SanofiCompletedIdiopathic Pulmonary FibrosisCzechia, Korea, Republic of, Mexico, Israel, Spain, Greece, Chile, Canada, Colombia, Turkey, Denmark, France, United States, Argentina, Australia, Germany, Italy, Portugal, United Kingdom
-
Bastiaan DriehuysNational Heart, Lung, and Blood Institute (NHLBI); University of Wisconsin,...CompletedIdiopathic Pulmonary FibrosisUnited States
-
Galapagos NVCompletedIdiopathic Pulmonary FibrosisSlovakia, Finland, France, Sweden, Bulgaria, Croatia, Oman, Romania, Ukraine
-
Parc de Salut MarHospitales Universitarios Virgen del RocíoCompletedIdiopathic Pulmonary FibrosisSpain
-
Boehringer IngelheimTerminatedIdiopathic Pulmonary FibrosisUnited States
-
Weill Medical College of Cornell UniversityNational Heart, Lung, and Blood Institute (NHLBI); University of Chicago; University... and other collaboratorsTerminatedIdiopathic Pulmonary FibrosisUnited States
-
Hopital FochCompletedPulmonary FibrosisFrance
-
Sohag UniversityCompleted
-
BiogenTerminatedIdiopathic Pulmonary FibrosisUnited States, Italy, Belgium, Czechia, Russian Federation, Korea, Republic of, Australia, France, Israel, Spain, Poland, Netherlands, Denmark, Greece, Argentina, Chile, United Kingdom
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisRussian Federation
-
Boehringer IngelheimCompleted
-
Bristol-Myers SquibbCompletedIdiopathic Pulmonary FibrosisUnited States, Mexico, Australia, Colombia, Chile, Peru
-
NYU Langone HealthStony Brook University; National Center for Research Resources (NCRR); Philips...CompletedPulmonary FibrosisUnited States
-
GlaxoSmithKlineCompletedIdiopathic Pulmonary FibrosisUnited Kingdom
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisSpain, United Kingdom, Italy, Belgium, Germany, Netherlands, Finland, Denmark
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisItaly
-
University Hospital, GrenobleCompletedIdiopathic Pulmonary FibrosisFrance
-
Boehringer IngelheimCompleted
-
patientMpower Ltd.Health Service Executive, IrelandCompletedIdiopathic Pulmonary FibrosisIreland
-
Gilead SciencesTerminatedLiver Fibrosis Due to NASHUnited States, Canada, France, Italy, Germany, Puerto Rico, Spain, United Kingdom
-
Boehringer IngelheimNo longer availableIdiopathic Pulmonary FibrosisBrazil
-
Asahi Kasei Pharma CorporationCompletedIdiopathic Pulmonary FibrosisJapan
-
GlaxoSmithKlineTerminatedIdiopathic Pulmonary FibrosisUnited Kingdom
-
University of AarhusEurostarsUnknownFeasibility & Effect of a Tele-rehabilitation Program in Idiopathic Pulmonary Fibrosis (IPF) (3-IPF)Idiopathic Pulmonary FibrosisDenmark
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisCanada, United States, Netherlands, France, Italy, Germany
-
Royal Brompton & Harefield NHS Foundation TrustNational Institute for Health Research, United KingdomCompletedIdiopathic Pulmonary FibrosisUnited Kingdom
-
Royal Brompton & Harefield NHS Foundation TrustNational Institute for Health Research, United KingdomCompleted
-
Brigham and Women's HospitalNational Heart, Lung, and Blood Institute (NHLBI); University of Chicago; Columbia... and other collaboratorsCompletedIdiopathic Pulmonary FibrosisUnited States
-
Gilead SciencesTerminatedIdiopathic Pulmonary FibrosisUnited States, Spain, Korea, Republic of, Israel, Australia, Italy, Canada, United Kingdom, Switzerland, Germany, Poland, Czechia, Belgium, France
-
Genentech, Inc.CompletedIdiopathic Pulmonary FibrosisUnited States
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisGermany, United Kingdom, Ireland, France, Austria, Denmark, Finland, Italy, Norway, Sweden
-
Genentech, Inc.CompletedIdiopathic Pulmonary Fibrosis | Pulmonary FibrosisUnited States
-
Genentech, Inc.CompletedIdiopathic Pulmonary FibrosisUnited States
-
Hoffmann-La RocheInterMune Deutschland GmbHCompletedIdiopathic Pulmonary FibrosisGermany
-
ActelionCompletedIdiopathic Pulmonary FibrosisUnited States, France, Spain, Korea, Republic of, United Kingdom, Belgium, Japan, Australia, Canada, Czech Republic, Germany, Ireland, Israel, Italy, Switzerland